Search

everythinglearnresearchcommunity

for

Search:↓

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

DHT stops hair regrowth in mice, similar to human hair loss.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Cannabinoid receptor-1 signaling is essential for the survival and growth of human hair follicle stem cells.

Activating TRPV3 channels stops hair growth by killing hair follicle cells.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Melatonin receptors in hair follicles help regulate hair growth and could treat hair loss.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.

Cedrol may help reduce liver fat and fat cell growth caused by corticosteroids.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

Blocking glucocorticoid receptors improves glucose metabolism in a PCOS mouse model.

PPAR-γ may be a key target for treating alopecia areata and other skin conditions.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Certain gene variations are linked to better memory in healthy Chinese women.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

New findings explain how genetic changes, body clocks, and certain molecules affect tissue response to stress hormones.

Certain defective glucocorticoid receptor mutants move faster inside cell nuclei and work less effectively.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Finasteride may improve prostate cancer treatment outcomes.

Dutasteride and finasteride affect different cell types differently.

Megestrol acetate helps fat-derived stem cells grow, move, and turn into fat cells through a specific receptor.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.

Fluridil promotes hair growth safely and effectively for androgenetic alopecia.